Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung | 29 | 2018 | 10099 | 0.660 |
Why?
|
Chemokines, CC | 6 | 2007 | 286 | 0.590 |
Why?
|
Hypertension, Pulmonary | 9 | 2022 | 1605 | 0.480 |
Why?
|
Retinoids | 1 | 2012 | 99 | 0.390 |
Why?
|
Maternal-Fetal Exchange | 1 | 2012 | 454 | 0.340 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2012 | 2538 | 0.320 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 355 | 0.320 |
Why?
|
Tobacco Smoke Pollution | 2 | 2013 | 828 | 0.320 |
Why?
|
Smoking | 4 | 2012 | 9092 | 0.280 |
Why?
|
Bronchial Hyperreactivity | 4 | 2007 | 301 | 0.250 |
Why?
|
Asthma | 9 | 2011 | 6291 | 0.250 |
Why?
|
Cytokines | 13 | 2004 | 7453 | 0.230 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2909 | 0.220 |
Why?
|
Bile Acids and Salts | 1 | 2025 | 398 | 0.200 |
Why?
|
Receptors, Neurokinin-2 | 2 | 2001 | 24 | 0.200 |
Why?
|
Angiopoietins | 1 | 2002 | 86 | 0.200 |
Why?
|
MicroRNAs | 5 | 2015 | 3803 | 0.190 |
Why?
|
Neurokinin A | 1 | 2001 | 32 | 0.190 |
Why?
|
Bronchoalveolar Lavage Fluid | 8 | 2004 | 760 | 0.190 |
Why?
|
Growth Substances | 1 | 2002 | 759 | 0.170 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2012 | 3610 | 0.170 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 671 | 0.170 |
Why?
|
Signal Transduction | 6 | 2021 | 23645 | 0.170 |
Why?
|
Extracellular Matrix | 3 | 2016 | 1738 | 0.170 |
Why?
|
Phosphoproteins | 3 | 2018 | 2451 | 0.170 |
Why?
|
Pulmonary Surfactants | 4 | 2006 | 169 | 0.170 |
Why?
|
Lymphokines | 1 | 2002 | 924 | 0.160 |
Why?
|
Chemokine CCL11 | 6 | 2007 | 128 | 0.160 |
Why?
|
Collagen Type III | 2 | 2018 | 92 | 0.160 |
Why?
|
Lysosomes | 1 | 2025 | 938 | 0.160 |
Why?
|
Iron-Sulfur Proteins | 2 | 2019 | 84 | 0.160 |
Why?
|
Respiratory Mucosa | 4 | 2002 | 439 | 0.150 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2014 | 1656 | 0.150 |
Why?
|
Receptors, Chemokine | 2 | 2002 | 652 | 0.150 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 745 | 0.150 |
Why?
|
Proliferating Cell Nuclear Antigen | 3 | 2001 | 284 | 0.150 |
Why?
|
Mechanotransduction, Cellular | 3 | 2016 | 541 | 0.150 |
Why?
|
Epithelial Cells | 9 | 2013 | 3703 | 0.150 |
Why?
|
Fetus | 4 | 2012 | 1883 | 0.150 |
Why?
|
Mice | 36 | 2025 | 82029 | 0.150 |
Why?
|
Methacholine Chloride | 2 | 2011 | 220 | 0.140 |
Why?
|
Eosinophils | 4 | 2007 | 952 | 0.140 |
Why?
|
Gene Regulatory Networks | 3 | 2015 | 1752 | 0.140 |
Why?
|
Neurosecretory Systems | 1 | 1998 | 223 | 0.140 |
Why?
|
Lung Diseases | 3 | 2002 | 1944 | 0.140 |
Why?
|
Chromogranins | 1 | 1997 | 160 | 0.130 |
Why?
|
Thiolester Hydrolases | 1 | 1997 | 91 | 0.130 |
Why?
|
Vasculitis | 1 | 2000 | 525 | 0.130 |
Why?
|
Arteriosclerosis | 1 | 2000 | 1055 | 0.130 |
Why?
|
Carcinoma, Small Cell | 1 | 1998 | 419 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2016 | 2892 | 0.130 |
Why?
|
RNA, Messenger | 16 | 2012 | 12800 | 0.130 |
Why?
|
Glycine | 1 | 2019 | 672 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2004 | 4352 | 0.120 |
Why?
|
Animals | 46 | 2025 | 169246 | 0.120 |
Why?
|
Receptors, CCR3 | 2 | 2007 | 62 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 2002 | 1312 | 0.120 |
Why?
|
Hypersensitivity | 2 | 2002 | 1172 | 0.120 |
Why?
|
Sulfur | 1 | 2015 | 158 | 0.120 |
Why?
|
Cell Adhesion | 1 | 2021 | 3096 | 0.120 |
Why?
|
Chemokines | 2 | 2002 | 963 | 0.120 |
Why?
|
Mice, Inbred C57BL | 15 | 2019 | 22379 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2025 | 16045 | 0.120 |
Why?
|
Bronchi | 5 | 2006 | 850 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2000 | 1493 | 0.110 |
Why?
|
Fibrosis | 2 | 2018 | 2080 | 0.110 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 2 | 2004 | 49 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1334 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 979 | 0.110 |
Why?
|
Graft Rejection | 5 | 2004 | 4492 | 0.110 |
Why?
|
Feedback, Physiological | 1 | 2015 | 482 | 0.110 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3711 | 0.100 |
Why?
|
Immunohistochemistry | 12 | 2006 | 11095 | 0.100 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2014 | 207 | 0.100 |
Why?
|
Cotinine | 1 | 2012 | 206 | 0.100 |
Why?
|
Endothelial Cells | 6 | 2025 | 3589 | 0.100 |
Why?
|
Proteolipids | 2 | 2002 | 112 | 0.100 |
Why?
|
Endothelium, Vascular | 2 | 2025 | 4427 | 0.090 |
Why?
|
Receptors, Retinoic Acid | 1 | 2012 | 229 | 0.090 |
Why?
|
Mice, Inbred Strains | 3 | 2004 | 1765 | 0.090 |
Why?
|
Pulmonary Alveoli | 3 | 2014 | 665 | 0.090 |
Why?
|
Response Elements | 1 | 2012 | 307 | 0.090 |
Why?
|
Cells, Cultured | 11 | 2021 | 19015 | 0.090 |
Why?
|
Bronchoconstriction | 3 | 2006 | 141 | 0.090 |
Why?
|
Transcription Factors | 6 | 2016 | 12168 | 0.090 |
Why?
|
Maternal Behavior | 1 | 2012 | 307 | 0.090 |
Why?
|
Muscle, Smooth | 3 | 2004 | 931 | 0.090 |
Why?
|
Epidermal Growth Factor | 2 | 2004 | 697 | 0.090 |
Why?
|
Leukocytes | 1 | 1998 | 2035 | 0.090 |
Why?
|
Progesterone | 1 | 2014 | 752 | 0.080 |
Why?
|
Cilia | 1 | 2013 | 498 | 0.080 |
Why?
|
Gene Expression | 6 | 2011 | 7598 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2013 | 717 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 1998 | 1892 | 0.080 |
Why?
|
Pregnancy | 8 | 2012 | 30256 | 0.080 |
Why?
|
Enzyme Activation | 3 | 2014 | 3590 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2002 | 4937 | 0.080 |
Why?
|
Chemokine CCL24 | 1 | 2007 | 8 | 0.080 |
Why?
|
Cell Count | 3 | 2002 | 1832 | 0.080 |
Why?
|
Models, Animal | 5 | 2021 | 2120 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2599 | 0.070 |
Why?
|
Phosphatidylglycerols | 1 | 2006 | 35 | 0.070 |
Why?
|
Estradiol | 1 | 2014 | 1951 | 0.070 |
Why?
|
Ovalbumin | 3 | 2004 | 677 | 0.070 |
Why?
|
Guinea Pigs | 5 | 2002 | 1310 | 0.070 |
Why?
|
Lipopolysaccharides | 3 | 2004 | 2219 | 0.070 |
Why?
|
Blotting, Northern | 4 | 2001 | 1550 | 0.070 |
Why?
|
Mice, Knockout | 10 | 2013 | 14488 | 0.070 |
Why?
|
Pneumonia | 3 | 2007 | 2163 | 0.070 |
Why?
|
Fibrinolysin | 1 | 2006 | 130 | 0.070 |
Why?
|
Plasminogen | 1 | 2006 | 144 | 0.070 |
Why?
|
Up-Regulation | 3 | 2014 | 4146 | 0.060 |
Why?
|
Gene Expression Profiling | 5 | 2006 | 9538 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 5 | 2018 | 8128 | 0.060 |
Why?
|
Autophagy | 1 | 2013 | 1349 | 0.060 |
Why?
|
LDL-Receptor Related Proteins | 2 | 2015 | 118 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 3252 | 0.060 |
Why?
|
Bronchial Provocation Tests | 2 | 2004 | 216 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 615 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4580 | 0.060 |
Why?
|
Trachea | 4 | 2013 | 1095 | 0.060 |
Why?
|
Heart Transplantation | 3 | 2004 | 3301 | 0.060 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2025 | 62 | 0.060 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 1 | 2004 | 44 | 0.060 |
Why?
|
Genes, T-Cell Receptor | 1 | 2004 | 29 | 0.060 |
Why?
|
Lung Neoplasms | 4 | 2014 | 13586 | 0.060 |
Why?
|
Cell Line | 5 | 2012 | 15597 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2810 | 0.060 |
Why?
|
Rats | 7 | 2018 | 23760 | 0.060 |
Why?
|
Graft Survival | 3 | 2004 | 3887 | 0.060 |
Why?
|
Placenta | 1 | 2012 | 1725 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2014 | 10474 | 0.050 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2006 | 567 | 0.050 |
Why?
|
Interleukin-13 | 2 | 2004 | 390 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2004 | 168 | 0.050 |
Why?
|
Nitric Oxide Synthase | 2 | 2004 | 911 | 0.050 |
Why?
|
Gestational Age | 2 | 2012 | 3621 | 0.050 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2001 | 133 | 0.050 |
Why?
|
Female | 22 | 2022 | 397192 | 0.050 |
Why?
|
Male | 25 | 2025 | 364719 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2015 | 11928 | 0.050 |
Why?
|
Pulmonary Surfactant-Associated Proteins | 1 | 2002 | 18 | 0.050 |
Why?
|
Collectins | 1 | 2002 | 18 | 0.050 |
Why?
|
Cyclic AMP | 1 | 2006 | 1470 | 0.050 |
Why?
|
Capsaicin | 2 | 2001 | 235 | 0.050 |
Why?
|
Apoproteins | 1 | 2002 | 45 | 0.050 |
Why?
|
Humans | 38 | 2025 | 768166 | 0.050 |
Why?
|
Genes, RAG-1 | 1 | 2002 | 68 | 0.050 |
Why?
|
Extracellular Space | 1 | 2004 | 563 | 0.050 |
Why?
|
Bombesin | 2 | 1999 | 35 | 0.050 |
Why?
|
Receptors, Cell Surface | 3 | 2006 | 2819 | 0.050 |
Why?
|
Angiopoietin-1 | 1 | 2002 | 133 | 0.050 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2001 | 48 | 0.050 |
Why?
|
PPAR gamma | 2 | 2015 | 486 | 0.050 |
Why?
|
Disease Models, Animal | 9 | 2019 | 18349 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2004 | 354 | 0.050 |
Why?
|
Peroxidases | 1 | 2002 | 135 | 0.050 |
Why?
|
Nebulizers and Vaporizers | 1 | 2002 | 139 | 0.050 |
Why?
|
Barium Compounds | 1 | 2001 | 19 | 0.050 |
Why?
|
Major Histocompatibility Complex | 1 | 2004 | 877 | 0.050 |
Why?
|
Cell Differentiation | 2 | 1999 | 11669 | 0.050 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2004 | 617 | 0.050 |
Why?
|
Bronchoconstrictor Agents | 1 | 2001 | 77 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2004 | 444 | 0.050 |
Why?
|
Receptors, Opioid | 1 | 2001 | 145 | 0.050 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2016 | 702 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 319 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 748 | 0.050 |
Why?
|
Mast Cells | 2 | 2000 | 1406 | 0.040 |
Why?
|
Antigens, CD | 2 | 2002 | 4035 | 0.040 |
Why?
|
Genetic Linkage | 1 | 2005 | 2342 | 0.040 |
Why?
|
Immunization | 2 | 2002 | 1219 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2005 | 1117 | 0.040 |
Why?
|
Respiratory Hypersensitivity | 1 | 2002 | 272 | 0.040 |
Why?
|
Transcription, Genetic | 4 | 2004 | 7608 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3800 | 0.040 |
Why?
|
CD40 Ligand | 1 | 2002 | 528 | 0.040 |
Why?
|
Antibody Formation | 2 | 2002 | 1393 | 0.040 |
Why?
|
Docosahexaenoic Acids | 1 | 2007 | 914 | 0.040 |
Why?
|
Peptides | 3 | 2001 | 4354 | 0.040 |
Why?
|
Computational Biology | 1 | 2012 | 3568 | 0.040 |
Why?
|
Apolipoproteins E | 2 | 2015 | 1461 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2002 | 587 | 0.040 |
Why?
|
Cholesterol | 2 | 2025 | 2914 | 0.040 |
Why?
|
Trans-Activators | 3 | 2016 | 2857 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 283 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2004 | 1441 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2025 | 18065 | 0.040 |
Why?
|
Professional-Family Relations | 1 | 2003 | 501 | 0.040 |
Why?
|
Capillary Permeability | 1 | 2002 | 772 | 0.040 |
Why?
|
Patient Care Planning | 2 | 2003 | 905 | 0.040 |
Why?
|
Gastrin-Releasing Peptide | 1 | 1998 | 36 | 0.040 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 1 | 1998 | 27 | 0.040 |
Why?
|
MAP Kinase Signaling System | 2 | 2004 | 1494 | 0.040 |
Why?
|
Cell Respiration | 1 | 2019 | 201 | 0.040 |
Why?
|
Perfusion | 2 | 2001 | 1401 | 0.040 |
Why?
|
Nitrosamines | 1 | 1998 | 86 | 0.040 |
Why?
|
Chlorides | 1 | 2001 | 666 | 0.040 |
Why?
|
Hypersensitivity, Immediate | 1 | 2001 | 349 | 0.040 |
Why?
|
Stem Cells | 1 | 2011 | 3537 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11879 | 0.040 |
Why?
|
Genetic Testing | 1 | 2011 | 3591 | 0.040 |
Why?
|
Calcitonin | 1 | 1999 | 328 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 166 | 0.040 |
Why?
|
Respiratory Insufficiency | 1 | 2006 | 1240 | 0.040 |
Why?
|
Cathepsins | 1 | 1999 | 243 | 0.040 |
Why?
|
Communication | 2 | 2003 | 3905 | 0.040 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1946 | 0.040 |
Why?
|
Chromogranin A | 1 | 1997 | 47 | 0.040 |
Why?
|
Isoenzymes | 1 | 2002 | 1688 | 0.030 |
Why?
|
Allergens | 2 | 2002 | 1443 | 0.030 |
Why?
|
Genes, ras | 1 | 1999 | 663 | 0.030 |
Why?
|
Hyperoxia | 1 | 1998 | 261 | 0.030 |
Why?
|
Gene Deletion | 1 | 2004 | 2675 | 0.030 |
Why?
|
Carotid Arteries | 1 | 2000 | 942 | 0.030 |
Why?
|
Mesoderm | 1 | 1999 | 679 | 0.030 |
Why?
|
Bronchitis | 1 | 1997 | 194 | 0.030 |
Why?
|
Germinal Center | 1 | 1999 | 380 | 0.030 |
Why?
|
Hyperplasia | 1 | 1999 | 1151 | 0.030 |
Why?
|
Oligopeptides | 1 | 2001 | 1194 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 1998 | 574 | 0.030 |
Why?
|
Antigens, Surface | 1 | 1999 | 1617 | 0.030 |
Why?
|
Fetal Heart | 1 | 1996 | 281 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2006 | 687 | 0.030 |
Why?
|
Benzylamines | 1 | 2015 | 251 | 0.030 |
Why?
|
Cricetinae | 1 | 1998 | 2423 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2001 | 1854 | 0.030 |
Why?
|
Mice, Inbred BALB C | 4 | 2004 | 6231 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 482 | 0.030 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 1998 | 329 | 0.030 |
Why?
|
Systems Theory | 1 | 2014 | 57 | 0.030 |
Why?
|
Benzoates | 1 | 2015 | 213 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2202 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2000 | 1110 | 0.030 |
Why?
|
Acute Disease | 2 | 2002 | 7243 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 1998 | 6124 | 0.030 |
Why?
|
Substance P | 1 | 1995 | 332 | 0.030 |
Why?
|
Inflammation | 3 | 2025 | 10873 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 1997 | 465 | 0.030 |
Why?
|
Sympathetic Nervous System | 1 | 1996 | 521 | 0.030 |
Why?
|
Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 2 | 2004 | 30 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2014 | 221 | 0.030 |
Why?
|
Histamine | 1 | 1995 | 496 | 0.030 |
Why?
|
Actins | 1 | 2000 | 2064 | 0.030 |
Why?
|
Interleukin-1 | 3 | 2002 | 1252 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2014 | 866 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2227 | 0.030 |
Why?
|
Cluster Analysis | 3 | 2006 | 2732 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 474 | 0.030 |
Why?
|
Nitric Oxide | 2 | 2004 | 2146 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2012 | 88 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 478 | 0.030 |
Why?
|
Interleukin-4 | 3 | 2002 | 1156 | 0.030 |
Why?
|
Compressive Strength | 2 | 2004 | 159 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2004 | 9615 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2012 | 455 | 0.020 |
Why?
|
Intensive Care Units | 2 | 2003 | 3800 | 0.020 |
Why?
|
Sirtuin 1 | 1 | 2013 | 247 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2014 | 590 | 0.020 |
Why?
|
Length of Stay | 2 | 2003 | 6498 | 0.020 |
Why?
|
3T3 Cells | 2 | 2004 | 1084 | 0.020 |
Why?
|
Pulmonary Fibrosis | 1 | 2015 | 506 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2003 | 5349 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2007 | 660 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 944 | 0.020 |
Why?
|
Mucus | 1 | 2013 | 346 | 0.020 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 246 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3514 | 0.020 |
Why?
|
Adult | 9 | 2022 | 223646 | 0.020 |
Why?
|
Child | 3 | 2019 | 80917 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 2007 | 10266 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 3814 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2486 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 381 | 0.020 |
Why?
|
Chemotactic Factors, Eosinophil | 2 | 2001 | 40 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2016 | 1191 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2479 | 0.020 |
Why?
|
Cytosol | 1 | 2013 | 887 | 0.020 |
Why?
|
Cell Lineage | 1 | 1999 | 2575 | 0.020 |
Why?
|
Drug Synergism | 1 | 2014 | 1760 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 874 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3428 | 0.020 |
Why?
|
Interferon-gamma | 3 | 2004 | 3160 | 0.020 |
Why?
|
NF-kappa B | 1 | 1998 | 2493 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2003 | 3269 | 0.020 |
Why?
|
Transplantation, Homologous | 3 | 2003 | 4833 | 0.020 |
Why?
|
Benzamides | 1 | 1995 | 1379 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 1998 | 1294 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 1009 | 0.020 |
Why?
|
Cell Death | 1 | 2014 | 1679 | 0.020 |
Why?
|
Monocytes | 1 | 1998 | 2605 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 778 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2002 | 4793 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2013 | 1074 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1151 | 0.020 |
Why?
|
Interleukins | 2 | 2004 | 796 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1143 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2643 | 0.020 |
Why?
|
Critical Care | 1 | 2000 | 2715 | 0.020 |
Why?
|
Phenotype | 2 | 2013 | 16726 | 0.020 |
Why?
|
Clone Cells | 1 | 2011 | 1670 | 0.020 |
Why?
|
Animals, Newborn | 2 | 2006 | 2678 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2011 | 725 | 0.020 |
Why?
|
Middle Aged | 6 | 2022 | 223492 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1319 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2012 | 9561 | 0.020 |
Why?
|
Promoter Regions, Genetic | 3 | 2004 | 5797 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 1999 | 4413 | 0.020 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 75 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2001 | 1903 | 0.020 |
Why?
|
Piperidines | 1 | 1995 | 1667 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2149 | 0.020 |
Why?
|
Protease Nexins | 1 | 2005 | 39 | 0.020 |
Why?
|
Serpin E2 | 1 | 2005 | 48 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2204 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3611 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9343 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 42669 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1966 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36535 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2457 | 0.020 |
Why?
|
Adolescent | 3 | 2019 | 89169 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2006 | 915 | 0.020 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2006 | 324 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2004 | 6229 | 0.020 |
Why?
|
Lod Score | 1 | 2005 | 600 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2006 | 279 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2015 | 1960 | 0.020 |
Why?
|
Concanavalin A | 1 | 2004 | 190 | 0.020 |
Why?
|
Lipid A | 1 | 2004 | 70 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3628 | 0.010 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2004 | 32 | 0.010 |
Why?
|
Surface Tension | 1 | 2004 | 43 | 0.010 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2004 | 38 | 0.010 |
Why?
|
Radiation Chimera | 1 | 2004 | 216 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2011 | 809 | 0.010 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2004 | 220 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2006 | 461 | 0.010 |
Why?
|
Serum Response Factor | 1 | 2004 | 78 | 0.010 |
Why?
|
Risk Factors | 1 | 2011 | 74944 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2003 | 94 | 0.010 |
Why?
|
Early Growth Response Protein 1 | 1 | 2004 | 133 | 0.010 |
Why?
|
Antigens | 2 | 2002 | 1442 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 2003 | 249 | 0.010 |
Why?
|
Models, Biological | 2 | 2014 | 9495 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 2004 | 330 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2003 | 196 | 0.010 |
Why?
|
Sp1 Transcription Factor | 1 | 2004 | 143 | 0.010 |
Why?
|
Heart | 1 | 1996 | 4446 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 633 | 0.010 |
Why?
|
Phospholipids | 1 | 2006 | 787 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 514 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1596 | 0.010 |
Why?
|
Hemorrhage | 1 | 1994 | 3467 | 0.010 |
Why?
|
Kinetics | 2 | 2002 | 6329 | 0.010 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2002 | 147 | 0.010 |
Why?
|
Receptors, Interleukin-13 | 1 | 2002 | 13 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5210 | 0.010 |
Why?
|
Interleukin-13 Receptor alpha1 Subunit | 1 | 2002 | 23 | 0.010 |
Why?
|
Regeneration | 1 | 2011 | 1524 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2828 | 0.010 |
Why?
|
Phosphorylation | 2 | 2004 | 8317 | 0.010 |
Why?
|
Homozygote | 1 | 2006 | 1779 | 0.010 |
Why?
|
Osmotic Pressure | 1 | 2002 | 137 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2002 | 313 | 0.010 |
Why?
|
Thymidine | 1 | 2001 | 297 | 0.010 |
Why?
|
Blotting, Western | 2 | 2001 | 5027 | 0.010 |
Why?
|
Aerosols | 1 | 2004 | 634 | 0.010 |
Why?
|
Interleukin-5 | 1 | 2002 | 267 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 582 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2006 | 1676 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 588 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 60066 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 257 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2002 | 243 | 0.010 |
Why?
|
Multigene Family | 1 | 2004 | 1081 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6283 | 0.010 |
Why?
|
Patient Care Team | 2 | 2003 | 2523 | 0.010 |
Why?
|
Tissue Plasminogen Activator | 1 | 2006 | 1165 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2004 | 1609 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2004 | 1497 | 0.010 |
Why?
|
APACHE | 1 | 2000 | 268 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 1524 | 0.010 |
Why?
|
Syntaxin 1 | 1 | 1999 | 29 | 0.010 |
Why?
|
Choline | 1 | 2001 | 522 | 0.010 |
Why?
|
RNA Stability | 1 | 2001 | 319 | 0.010 |
Why?
|
Mutation | 2 | 2019 | 30238 | 0.010 |
Why?
|
Haplotypes | 1 | 2005 | 2722 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2002 | 598 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2002 | 825 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2001 | 794 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2004 | 1183 | 0.010 |
Why?
|
T-Box Domain Proteins | 1 | 2002 | 472 | 0.010 |
Why?
|
Time Factors | 4 | 2003 | 40218 | 0.010 |
Why?
|
Skin Tests | 1 | 2001 | 639 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 2002 | 3728 | 0.010 |
Why?
|
Freund's Adjuvant | 1 | 1999 | 144 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4938 | 0.010 |
Why?
|
Flavonoids | 1 | 2002 | 447 | 0.010 |
Why?
|
Case Management | 1 | 2000 | 277 | 0.010 |
Why?
|
Th1 Cells | 1 | 2003 | 1042 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1999 | 420 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2001 | 704 | 0.010 |
Why?
|
Gene Targeting | 1 | 2002 | 841 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 2004 | 1506 | 0.010 |
Why?
|
Th2 Cells | 1 | 2003 | 1078 | 0.010 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1999 | 318 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2001 | 892 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2002 | 1353 | 0.010 |
Why?
|
Chimera | 1 | 1999 | 454 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1998 | 213 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14729 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1998 | 826 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1245 | 0.010 |
Why?
|
Immunoglobulin Class Switching | 1 | 1999 | 289 | 0.010 |
Why?
|
Vagotomy | 1 | 1997 | 83 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 3284 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2002 | 1715 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7577 | 0.010 |
Why?
|
Obstetric Labor, Premature | 1 | 1998 | 268 | 0.010 |
Why?
|
Palliative Care | 2 | 2003 | 3643 | 0.010 |
Why?
|
Models, Genetic | 1 | 2006 | 3447 | 0.010 |
Why?
|
Mice, SCID | 1 | 2002 | 2627 | 0.010 |
Why?
|
Papio | 1 | 1998 | 671 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1997 | 262 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2709 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15454 | 0.010 |
Why?
|
Cholinergic Antagonists | 1 | 1997 | 167 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1999 | 1754 | 0.010 |
Why?
|
Pyrilamine | 1 | 1995 | 13 | 0.010 |
Why?
|
Catecholamines | 1 | 1996 | 389 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12421 | 0.010 |
Why?
|
Receptors, Histamine | 1 | 1995 | 23 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2001 | 914 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6082 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2012 | 22291 | 0.010 |
Why?
|
Transfection | 1 | 2002 | 5755 | 0.010 |
Why?
|
Cell Membrane | 1 | 2004 | 3655 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 1999 | 1563 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2004 | 3228 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5505 | 0.010 |
Why?
|
Lymphocytes | 1 | 2001 | 2614 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1169 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 81762 | 0.010 |
Why?
|
Organ Specificity | 1 | 1998 | 1968 | 0.010 |
Why?
|
Antigen Presentation | 1 | 1999 | 1251 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1996 | 2560 | 0.010 |
Why?
|
Health Services Research | 1 | 2000 | 1815 | 0.010 |
Why?
|
Neuroendocrine Tumors | 1 | 1999 | 659 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 2295 | 0.010 |
Why?
|
Fibroblasts | 1 | 2002 | 4176 | 0.010 |
Why?
|
Cell Separation | 1 | 1998 | 1728 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 4473 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4528 | 0.010 |
Why?
|
Aged | 3 | 2016 | 171504 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 1999 | 6395 | 0.010 |
Why?
|
RNA | 1 | 2001 | 2720 | 0.010 |
Why?
|
Neuropeptides | 1 | 1997 | 951 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17622 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 10760 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2002 | 4415 | 0.000 |
Why?
|
Odds Ratio | 1 | 2000 | 9669 | 0.000 |
Why?
|
Survival Analysis | 1 | 2000 | 10101 | 0.000 |
Why?
|
Dendritic Cells | 1 | 1999 | 2747 | 0.000 |
Why?
|
Boston | 1 | 2000 | 9374 | 0.000 |
Why?
|
Massachusetts | 1 | 2000 | 8890 | 0.000 |
Why?
|
Infant, Newborn | 2 | 1998 | 26422 | 0.000 |
Why?
|
Oxygen | 1 | 1998 | 4270 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2000 | 12543 | 0.000 |
Why?
|
Logistic Models | 1 | 2000 | 13290 | 0.000 |
Why?
|
Radiography | 1 | 1994 | 6983 | 0.000 |
Why?
|
Myocardium | 1 | 1996 | 4788 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2000 | 15948 | 0.000 |
Why?
|
Chronic Disease | 1 | 1997 | 9384 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39348 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1998 | 9263 | 0.000 |
Why?
|
Cohort Studies | 1 | 2003 | 41754 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2002 | 13676 | 0.000 |
Why?
|
Neurons | 1 | 1996 | 9514 | 0.000 |
Why?
|
Prospective Studies | 1 | 2000 | 54926 | 0.000 |
Why?
|
United States | 1 | 2003 | 73039 | 0.000 |
Why?
|